Study of Salirasib to Treat Non-Small Cell Lung Cancer
This study has been completed.
Sponsor:
Concordia Pharmaceuticals, Inc
Information provided by:
Concordia Pharmaceuticals, Inc
ClinicalTrials.gov Identifier:
NCT00531401
First received: September 17, 2007
Last updated: June 8, 2011
Last verified: June 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | November 2009 |
| Primary Completion Date: | November 2009 (Final data collection date for primary outcome measure) |